Literature DB >> 6970552

Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis.

M R Laurent, G S Panayi, P Shepherd.   

Abstract

Raised levels of circulating immune complexes were found in the plasma of 47% of patients with psoriasis and in 58% of those with psoriatic arthritis. The mean levels were significantly raised when compared with normals, but there was no difference between the 2 patient groups. The levels of acute phase proteins (C-reactive protein, fibrinogen, alpha-1-antitrypsin, and the 9th component of complement) were normal in those patients with psoriasis but were significantly raised in patients with psoriatic arthritis. Serum immunoglobulin G and A levels were equally raised in both patient groups, immunoglobulin M being normal. C-reactive protein and fibrinogen gave the best correlation with the clinical index of disease activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970552      PMCID: PMC1000659          DOI: 10.1136/ard.40.1.66

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

2.  Defective function of T lymphocytes in psoriasis.

Authors:  W Glinski; S Obałek; A Langner; S Jabłonska; M Haftek
Journal:  J Invest Dermatol       Date:  1978-02       Impact factor: 8.551

3.  Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera.

Authors:  K B Reid; D M Lowe; R R Porter
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

4.  Microcirculation in psoriatic skin.

Authors:  I M Braverman; A Yen
Journal:  J Invest Dermatol       Date:  1974-05       Impact factor: 8.551

5.  Familial occurrence of psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

6.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

7.  Capillaroscopic observations in rheumatic diseases.

Authors:  W Redisch; E J Messina; G Hughes; C McEwen
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

8.  Serum ceruloplasmin concentration in rheumatoid arthritis, ankylosing spondylitis, psoriasis and sarcoidosis.

Authors:  P Koskelo; M Kekki; M Virkkunen; A Lassus; T Somer
Journal:  Acta Rheumatol Scand       Date:  1966

9.  Relationship between IgG complexes and anti-IgG antibodies in rheumatoid arthritis.

Authors:  E Munthe
Journal:  Acta Rheumatol Scand       Date:  1970

10.  Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.

Authors:  H S Luthra; F C McDuffie; G G Hunder; E A Samayoa
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

View more
  16 in total

Review 1.  [Psoriatic arthritis : a permanent challenge for rheumatologists and patients--Part 1: epidemiology, pathogenesis and clinical course].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

Review 2.  Outcome measures in psoriatic arthritis clinical trials.

Authors:  Soumya M Reddy; Clifton O Bingham III
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

3.  Circulating immune complexes in untreated psoriasis. A comparison of Raji-cell radioimmunoassay and polymorphonuclear leukocyte phagocytosis.

Authors:  L Lindholm; H Mobacken; B L Magnusson
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 4.  Evolution of the psoriatic arthritis concept and its relationship to the spondarthritides.

Authors:  J M Moll
Journal:  Clin Rheumatol       Date:  1982-09       Impact factor: 2.980

5.  Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.

Authors:  M D Chard; J Calvin; C P Price; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

6.  Activity of some lysosomal enzyme in rheumatoid and psoriatic arthritis.

Authors:  D Mikulíková; M Stancíková; K Trnavský; F Vlcek
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

7.  Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.

Authors:  Patrick A M Jansen; Diana Rodijk-Olthuis; Edward J Hollox; Marijke Kamsteeg; Geuranne S Tjabringa; Gys J de Jongh; Ivonne M J J van Vlijmen-Willems; Judith G M Bergboer; Michelle M van Rossum; Elke M G J de Jong; Martin den Heijer; Andrea W M Evers; Mieke Bergers; John A L Armour; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

8.  Nephrotic syndrome preceding psoriasis in children.

Authors:  Arvind Bagga; Shina Menon; Pankaj Hari; Mukta Mantan; Amit Dinda
Journal:  Pediatr Nephrol       Date:  2007-04-25       Impact factor: 3.714

Review 9.  Uveitis. A review.

Authors:  C Y Lowder; D H Char
Journal:  West J Med       Date:  1984-03

10.  Abnormal T-cell function in patients with psoriatic arthritis: evidence for decreased interleukin 2 production.

Authors:  J G Fort; J B Smith; J L Abruzzo
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.